These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 15133179

  • 1. The roles of Smad2 and Smad3 in the development of chemically induced skin tumors in mice.
    Tannehill-Gregg SH, Kusewitt DF, Rosol TJ, Weinstein M.
    Vet Pathol; 2004 May; 41(3):278-82. PubMed ID: 15133179
    [Abstract] [Full Text] [Related]

  • 2. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
    Alvarez J, Serra R.
    Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor-beta signaling helps specify tumor type in DMBA and hormone-induced mammary cancers.
    Crowley MR, Frost A, Chen DT, Baffi MO, Nicola T, Serra R.
    Differentiation; 2006 Feb; 74(1):40-52. PubMed ID: 16466399
    [Abstract] [Full Text] [Related]

  • 4. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
    Tian F, Byfield SD, Parks WT, Stuelten CH, Nemani D, Zhang YE, Roberts AB.
    Cancer Res; 2004 Jul 01; 64(13):4523-30. PubMed ID: 15231662
    [Abstract] [Full Text] [Related]

  • 5. Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta.
    Yang YA, Tang B, Robinson G, Hennighausen L, Brodie SG, Deng CX, Wakefield LM.
    Cell Growth Differ; 2002 Mar 01; 13(3):123-30. PubMed ID: 11959813
    [Abstract] [Full Text] [Related]

  • 6. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
    Báez A, Cantor A, Fonseca S, Marcos-Martinez M, Mathews LA, Muro-Cacho CA, Muñoz-Antonia T.
    Clin Cancer Res; 2005 May 01; 11(9):3191-7. PubMed ID: 15867212
    [Abstract] [Full Text] [Related]

  • 7. Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model.
    Vijayachandra K, Lee J, Glick AB.
    Cancer Res; 2003 Jul 01; 63(13):3447-52. PubMed ID: 12839923
    [Abstract] [Full Text] [Related]

  • 8. Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis.
    Yamagata H, Matsuzaki K, Mori S, Yoshida K, Tahashi Y, Furukawa F, Sekimoto G, Watanabe T, Uemura Y, Sakaida N, Yoshioka K, Kamiyama Y, Seki T, Okazaki K.
    Cancer Res; 2005 Jan 01; 65(1):157-65. PubMed ID: 15665291
    [Abstract] [Full Text] [Related]

  • 9. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.
    Brown KA, Pietenpol JA, Moses HL.
    J Cell Biochem; 2007 May 01; 101(1):9-33. PubMed ID: 17340614
    [Abstract] [Full Text] [Related]

  • 10. Suprabasal alpha 5 beta1 integrin expression stimulates formation of epidermal squamous cell carcinomas without disrupting TGFbeta signaling or inducing spindle cell tumors.
    Owens DM, Broad S, Yan X, Benitah SA, Watt FM.
    Mol Carcinog; 2005 Sep 01; 44(1):60-6. PubMed ID: 15924349
    [Abstract] [Full Text] [Related]

  • 11. Smad3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions.
    Phan TT, Lim IJ, Aalami O, Lorget F, Khoo A, Tan EK, Mukhopadhyay A, Longaker MT.
    J Pathol; 2005 Oct 01; 207(2):232-42. PubMed ID: 16052471
    [Abstract] [Full Text] [Related]

  • 12. TGF-beta3-dependent SMAD2 phosphorylation and inhibition of MEE proliferation during palatal fusion.
    Cui XM, Chai Y, Chen J, Yamamoto T, Ito Y, Bringas P, Shuler CF.
    Dev Dyn; 2003 Jul 01; 227(3):387-94. PubMed ID: 12815624
    [Abstract] [Full Text] [Related]

  • 13. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
    Leivonen SK, Ala-Aho R, Koli K, Grénman R, Peltonen J, Kähäri VM.
    Oncogene; 2006 Apr 27; 25(18):2588-600. PubMed ID: 16407850
    [Abstract] [Full Text] [Related]

  • 14. Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma.
    Fukuchi M, Nakajima M, Miyazaki T, Masuda N, Osawa H, Manda R, Tsukada K, Kato H, Kuwano H.
    J Surg Oncol; 2006 Jul 01; 94(1):51-6. PubMed ID: 16788944
    [Abstract] [Full Text] [Related]

  • 15. Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis.
    Go C, Li P, Wang XJ.
    Cancer Res; 1999 Jun 15; 59(12):2861-8. PubMed ID: 10383147
    [Abstract] [Full Text] [Related]

  • 16. Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis.
    Li AG, Lu SL, Zhang MX, Deng C, Wang XJ.
    Cancer Res; 2004 Nov 01; 64(21):7836-45. PubMed ID: 15520189
    [Abstract] [Full Text] [Related]

  • 17. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
    Gu L, Zhu YJ, Yang X, Guo ZJ, Xu WB, Tian XL.
    Acta Pharmacol Sin; 2007 Mar 01; 28(3):382-91. PubMed ID: 17303001
    [Abstract] [Full Text] [Related]

  • 18. Using RNA interference to identify the different roles of SMAD2 and SMAD3 in NIH/3T3 fibroblast cells.
    Zheng R, Xiong Q, Zuo B, Jiang S, Li F, Lei M, Deng C, Xiong Y.
    Cell Biochem Funct; 2008 Mar 01; 26(5):548-56. PubMed ID: 18506886
    [Abstract] [Full Text] [Related]

  • 19. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
    Cancer Res; 2004 Aug 01; 64(15):5200-11. PubMed ID: 15289325
    [Abstract] [Full Text] [Related]

  • 20. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
    Matsuzaki K, Kitano C, Murata M, Sekimoto G, Yoshida K, Uemura Y, Seki T, Taketani S, Fujisawa J, Okazaki K.
    Cancer Res; 2009 Jul 01; 69(13):5321-30. PubMed ID: 19531654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.